Vladimir Vračarić
Research Subjects
Vladimir Vračarić has a total of 16 co-authors. Here are the top co-authors by number of shared publications:
- Aleksandra Ilic
University of Novi Sad, Faculty of Medicine Novi Sad, Serbia + University of Novi Sad, Faculty of Medicine, Center for Pathology, Novi Sad, Serbia
1 shared publication - Bozidar Dejanovic
Faculty of Medicine, University of Novi Sad, 21000 Novi Sad, Serbia
1 shared publication - Dimitrije Damjanov
University Clinical Center of Vojvodina, Clinic for Gastroenterology and Hepatology, Novi Sad, Serbia + University of Novi Sad, Faculty of Medicine, Novi Sad, Serbia
1 shared publication - Jelena Ilic-Sabo
Faculty of Medicine, Center for Pathology and Histology, University of Novi Sad, University Clinical Center of Vojvodina, Novi Sad, Serbia
1 shared publication - Jovana Baljak
Center for Pathology and Histology, UKCV Novi, 21000 Novi Sad, Serbia
1 shared publication - Matilda Djolai
Center for Pathology and Histology, UKCV Novi, 21000 Novi Sad, Serbia
1 shared publication
Latest Publications
- Open Access
- 12 May 2025
- Published by MDPI AG in Diagnostics
- Vol. 15 (10) , 1219
Extramedullary Hematopoiesis in Gastric Mucosa
In this paper, pathohistological images of extramedullary hematopoiesis (EMH) in stomach mucosa in a 68-year-old female patient with treated osteomyelofibrosis are presented. The digestive system is a potential but uncommon site of EMH, with the gastric mucosa being particularly rare. According to the available literature, only 12 cases have been described.
- 12 May 2025
- Published by MDPI AG in Diagnostics
- Vol. 15 (10) , 1219
Open AccessExtramedullary Hematopoiesis in Gastric Mucosa
In this paper, pathohistological images of extramedullary hematopoiesis (EMH) in stomach mucosa in a 68-year-old female patient with treated osteomyelofibrosis are presented. The digestive system is a potential but uncommon site of EMH, with the gastric mucosa being particularly rare. According to the available literature, only 12 cases have been described.
- Open Access
- 22 September 2024
- Published by MDPI AG in Journal of Personalized Medicine
- Vol. 14 (9) , 1008
Visceral Fat Thickness, Serum Adiponectin, and Metabolic Syndrome in Patients with Colorectal Adenomas
Background/Objectives: Most cases of colorectal cancer (CRC) arise from adenomatous polyps. Identifying risk factors for colorectal adenoma (CRA) is critical for CRC prevention. Emerging evidence suggests a link between metabolic syndrome (MetS) and an elevated risk of CRA and CRC, potentially mediated by visceral obesity and adiponectin (APN). We aimed to evaluate the association between different markers of visceral obesity, serum APN, MetS, and the presence of CRA. Methods: A cross-sectional study was conducted at the University Clinical Center of Vojvodina, involving 120 patients, aged 40–75 years, who underwent colonoscopy between January 2022 and January 2023. Sixty patients with CRA were compared to 60 controls with normal colonoscopy findings. Visceral fat thickness (VFT) was measured using ultrasound (US), and bioelectrical impedance analysis (BIA) was used to assess visceral fat area (VFA). Serum APN levels, anthropometric measures, and MetS components were also evaluated. Results: Patients with CRA had significantly higher VFT measured by US (p < 0.05), but no significant differences were found in VFA measured by BIA, waist circumference (WC), or waist-to-hip ratio (WHR). MetS was significantly more prevalent in the CRA group (55% vs. 31.6%, p < 0.05), and logistic regression confirmed MetS as a significant predictor of CRA presence (OR = 2.6). Serum APN levels were inversely correlated with visceral fat measurements and MetS (p < 0.01), but no significant difference in APN levels was observed between patients with and without CRA. Conclusions: This study highlights the importance of VFT measured by US and the presence of MetS as significant factors associated with CRA.
- 22 September 2024
- Published by MDPI AG in Journal of Personalized Medicine
- Vol. 14 (9) , 1008
Open AccessVisceral Fat Thickness, Serum Adiponectin, and Metabolic Syndrome in Patients with Colorectal Adenomas
Background/Objectives: Most cases of colorectal cancer (CRC) arise from adenomatous polyps. Identifying risk factors for colorectal adenoma (CRA) is critical for CRC prevention. Emerging evidence suggests a link between metabolic syndrome (MetS) and an elevated risk of CRA and CRC, potentially mediated by visceral obesity and adiponectin (APN). We aimed to evaluate the association between different markers of visceral obesity, serum APN, MetS, and the presence of CRA. Methods: A cross-sectional study was conducted at the University Clinical Center of Vojvodina, involving 120 patients, aged 40–75 years, who underwent colonoscopy between January 2022 and January 2023. Sixty patients with CRA were compared to 60 controls with normal colonoscopy findings. Visceral fat thickness (VFT) was measured using ultrasound (US), and bioelectrical impedance analysis (BIA) was used to assess visceral fat area (VFA). Serum APN levels, anthropometric measures, and MetS components were also evaluated. Results: Patients with CRA had significantly higher VFT measured by US (p < 0.05), but no significant differences were found in VFA measured by BIA, waist circumference (WC), or waist-to-hip ratio (WHR). MetS was significantly more prevalent in the CRA group (55% vs. 31.6%, p < 0.05), and logistic regression confirmed MetS as a significant predictor of CRA presence (OR = 2.6). Serum APN levels were inversely correlated with visceral fat measurements and MetS (p < 0.01), but no significant difference in APN levels was observed between patients with and without CRA. Conclusions: This study highlights the importance of VFT measured by US and the presence of MetS as significant factors associated with CRA.